BlackRock »

Tourmaline Bio shares owned by BlackRock

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $22M 1.7M 12.86
2024-03-31 $11M 495k 22.90

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Tourmaline Bio

RA Capital Management
venBio Select Advisor
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Jennison Associates
Vanguard Group
Qiming U.S. Ventures Management
Rtw Investments
QVT Financial
Nantahala Capital Management
Vivo Capital
Citadel Advisors
Geode Capital Management
State Street Corporation

View all funds holding Tourmaline Bio